CD4 and COVID-19: At this point, the vast majority of adults in the United States have been infected and/or received at least one dose of the COVID-19 vaccine (37, 38); thus, going forward, characterizing pre-COVID-19 cross-reactive memory CD4+ and CD8+ T cells in unvaccinated COVID 19 patients will be very difficult (39).